Product Categories
| Country: | China |
|---|---|
| Tel: | 027-027-83314682 |
| Mobile: | 13554138826 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(Methylene)]bis[4,8,11-tris[(4-Methylphenyl)sulfon yl]- | C70H90N8O12S6 | 110078-47-2 | Details |
| 2-HYDROXY-3-METHOXY-3,3-DIPHENYLPROPANOIC ACID | C16H16O4 | 178306-51-9 | Details |
| PD184352 | C17H14ClF2IN2O2 | 212631-79-3 | Details |
| R788(FOSTAMATINIB DISODIUM) | C23H27FN6NaO9P | 1025687-58-4 | Details |
| Dorzolamide HCL | C10H17ClN2O4S3 | 130693-82-2 | Details |
| 6-N-Benzylamino-1-(4'-phenylbutoxy)Hexane | C23H33NO | 97664-55-6 | Details |
| 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | C26H31N3O8 | 239463-85-5 | Details |
| 1-[4-[(6-Bromohexyl)oxy]butyl]benzene | C16H25BrO | 94749-73-2 | Details |
| 5-Bromoacetyl-2-hydroxybenzaldehyde | C9H7BrO3 | 115787-50-3 | Details |
| 4-[(Biphenyl-2-ylcarbonyl)amino]benzoic acid | C20H15NO3 | 168626-74-2 | Details |
| Tamibarotene | C22H25NO3 | 94497-51-5 | Details |
| Etanercept | H4NO3V | 185243-69-0 | Details |
| 4H-Thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, (6S) | C8H8OS2 | 147086-79-1 | Details |
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Plerixafor | C28H54N8 | 110078-46-1 | Details |
| (3S,5S)-3-methyl-2,2-dioxo-2$l^{6},9-dithiabicyclo[4.3.0]nona-7,10-die n-5-ol | C8H10O3S2 | 147086-81-5 | Details |
| Salmeterol Xinafoate | C36H45NO7 | 94749-08-3 | Details |
| 1,4,8,11-TETRAAZACYCLOTETRADECANE | C10H24N4 | 295-37-4 | Details |
| Alfacalcidol | C27H44O2 | 41294-56-8 | Details |
| 3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one | C20H28O3 | 82543-15-5 | Details |
| PD0325901 | C16H14F3IN2O4 | 391210-10-9 | Details |
| Efaproxiral Sodium | C20H24NNaO4 | 170787-99-2 | Details |
| RU 58841 | C17H18F3N3O3 | 154992-24-2 | Details |
| Trastuzumab | C10H14N6O5 | 180288-69-1 | Details |
| 2-methyl-4-(2-methyl-benzoylamino)-benzoic acid | C16H15NO3 | 317374-08-6 | Details |
| 7-CHLORO-1,2,3,4-TETRAHYDRO-BENZO[B]AZEPIN-5-ONE | C10H10ClNO | 160129-45-3 | Details |
| Tirofiban HCL | C22H39ClN2O6S | 150915-40-5 | Details |
| Argatroban | C23H36N6O5S | 74863-84-6 | Details |
| Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
| RituxiMab | C6416H9874N1688O1987S44 | 174722-31-7 | Details |
| NVP-BEZ235 | C30H23N5O | 915019-65-7 | Details |
| Latanoprost | C26H40O5 | 130209-82-4 | Details |
| OMalizuMab | 242138-07-4 | Details |
| 3b,5-Dihydroxy-6b,7b:15b,16b-diMethylene-5b-androstan-17-one | C21H30O3 | 82543-16-6 | Details |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
| Rotigotine hydrochloride | C19H26ClNOS | 125572-93-2 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | C19H18IN3O | 886230-77-9 | Details |
| 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one | C13H13BrClN3O | 1016636-76-2 | Details |
| Tocilizumab | C14H12O3 | 375823-41-9 | Details |
| BevacizuMab | C6638H10160N1720O2108S44 | 216974-75-3 | Details |
| (R)-4-(tert-Butoxycarbonyl)morpholine-2-carboxylic acid | C10H17NO5 | 884512-77-0 | Details |
| pertuzuMab | C17H27NO2 | 380610-27-5 | Details |
| 2-AMino-5-[(4-fluorobenzyl)aMino]-1-nitrobenzene | C13H12FN3O2 | 150812-21-8 | Details |
| NVP-BGT226 | C28H25F3N6O2.C4H4O4 | 1245537-68-1 | Details |
| 4-Fluoro-5-hydroxy-2-Methylindole | C9H8FNO | 288385-88-6 | Details |
| Travoprost | C26H35F3O6 | 157283-68-6 | Details |
| tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | C14H22N4O2 | 571188-59-5 | Details |
| adaliMuMab | C6428H9912N1694O1987S46 | 331731-18-1 | Details |
| Bexarotene | C24H28O2 | 153559-49-0 | Details |
| (2S)-N-(2,6-DiMethylphenyl)-2-piperidinecarboxaMide) | C14H20N2O | 27262-40-4 | Details |
| 1-BOC-4-(6-NITROPYRIDIN-3-YL)PIPERAZINE | C14H20N4O4 | 571189-16-7 | Details |
| vandetanib interMediate | C16H21N3O3 | 264208-69-7 | Details |
| 4-CHLORO-7-(3-CHLORO-PROPOXY)-6-METHOXY-QUINOLINE-3-CARBONITRILE | C14H12Cl2N2O2 | 214470-68-5 | Details |
| N-methyl-2-sulfanylbenzamide | C8H9NOS | 20054-45-9 | Details |
| Denosumab | C6404H9912N1724O2004S50 | 615258-40-7 | Details |
| N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzaMide | C27H26N4O2S | 885126-35-2 | Details |
| 3',5'-di-o-p-chlorobenzoyl-2-deoxy-5-azacytosine | C22H18Cl2N4O6 | 1034301-08-0 | Details |
| (2S,3S)-3-AMino-N-cyclopropyl-2-hydroxyhexanaMide hydrochloride | C9H18N2O2.HCl | 944716-73-8 | Details |
| Drospirenone | C24H30O3 | 67392-87-4 | Details |
| luoroMethalone | C22H29FO4 | 426-13-1 | Details |
| Infliximab | Details |
| (S)-6-CHLORO-1,1-DIOXO-1,2,3,4-TETRAHYDRO-1LAMBDA*6*-THIENO[3,2-E][1,2]THIAZIN-4-OL | C6H6ClNO3S2 | 160982-16-1 | Details |
| 4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- | C18H14ClFN4O4 | 314771-88-5 | Details |
| Pramipexole impurity 7 | C7H11N3S | 106092-09-5 | Details |
| 4-chloro-7-Methoxyquinoline-6-carboxaMide | C11H9ClN2O2 | 417721-36-9 | Details |
| FG-4592 interMediate | C17H13NO4 | 1455091-10-7 | Details |
| (S)-3-AMINOPIPERIDINE-2-ONE | C5H10N2O | 34294-79-6 | Details |
| (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | C10H16N2O6S3 | 154127-42-1 | Details |
| NLG919;1-CYCLOHEXYL-2-(5H-IMIDAZO[5,1-A]ISOINDOL-5-YL)ETHANOL | C18H22N2O | 1402836-58-1 | Details |
| (-)-Corey lactone diol | C8H12O4 | 32233-40-2 | Details |
| N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide | C14H22N4O | 262368-30-9 | Details |
| Brinzolamide | C12H21N3O5S3 | 138890-62-7 | Details |
| D-Tryptophan, N-[N-[(1,1-dimethylethoxy)carbonyl]-2-methylalanyl]- | C20H27N3O5 | 159634-94-3 | Details |
| (S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | C17H16FN3O | 870281-86-0 | Details |
| Nivolumab | 946414-94-4 | Details |
| Alirocumab | 1245916-14-6 | Details |
| Zoledronic acid | C5H10N2O7P2 | 118072-93-8 | Details |
| Rituximab | Details |
| 4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | C13H12FN3O2 | 757251-39-1 | Details |
| 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| TERT-BUTYL 6-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE | C14H19NO3 | 158984-83-9 | Details |
| 3-(2-BroMoacetyl)-5-chloro-2-thiophenesulfonaMide | C6H5BrClNO3S2 | 160982-11-6 | Details |
| 2'-deoxy-2'-fluoro-2'-C-methyluridine | C10H13FN2O5 | 863329-66-2 | Details |
| 3-(2-chloropyriMidin-4-yl)-1-Methylindole | C13H10ClN3 | 1032452-86-0 | Details |
| Pramipexole dihydrochloride | C10H19Cl2N3S | 104632-25-9 | Details |
| PraMipexole | C10H20ClN3OS | 191217-81-9 | Details |
| (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine | C18H16ClFN4O2 | 314771-76-1 | Details |
| 1,3-Piperidinedicarboxylic acid, 3-(phenylMethyl)-, 1-(1,1-diMethylethyl) ester, (3R)- | C18H25NO4 | 339539-81-0 | Details |
| Evolocumab | 1256937-27-5 | Details |
| AclidiniuM broMide | C13H10BrN | 320345-99-1 | Details |
| Panitumumab | 339177-26-3 | Details |
| Obinutuzumab | 949142-50-1 | Details |
| FG-4592 | C19H16N2O5 | 808118-40-3 | Details |
| BriMonidine D-tartrate | C15H16BrN5O6 | 70359-46-5 | Details |
| Trandolapril | C24H34N2O5 | 87679-37-6 | Details |
| 1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose | C19H15Cl3O5 | 3601-90-9 | Details |
| N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester | C18H17F5NO5P | 1334513-02-8 | Details |
| 3-O-Methyldopamine hydrochloride | C9H13NO2.ClH | 1477-68-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||